Guardant Health Inc ECLIPSE Study Results Investor Call Transcript
Good day, everyone, and welcome to the Guardant Health ECLIPSE results. I would now like to hand the conference over to Alex Kleban. Please go ahead, sir.
Thank you. Earlier today, Guardant Health released a readout from its ECLIPSE study. Joining me today from Guardant to discuss the results are Helmy Eltoukhy, Co-CEO; AmirAli Talasaz, co-CEO; and Mike Bell, Chief Financial Officer.
Before we begin, I'd like to remind you that during this call, management will make forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled forward-looking statements in the press release Guardant issued today.
For a more complete [listen] description, please see the Risk Factors section of the company's annual report on Form 10-K for the year ended December 31, 2021, and in its other filings with the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |